Dow Up 1.31% Nasdaq Up 2.40%

Ironwood Pharmaceuticals, Inc. (IRWD)

-NasdaqGS
13.08 Up 0.03(0.23%) 4:00PM EDT
|After Hours : 13.12 Up 0.04 (0.31%) 4:00PM EDT - Nasdaq Real Time Price
Prev Close:13.05
Open:13.16
Bid:13.10 x 800
Ask:13.12 x 800
1y Target Est:14.42
Beta:1.94
Next Earnings Date: 4-Nov-14IRWD Earnings announcement
Day's Range:13.00 - 13.42
52wk Range:8.95 - 15.95
Volume:843,374
Avg Vol (3m):1,250,740
Market Cap:1.82B
P/E (ttm):N/A
EPS (ttm):-1.76
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IRWD

Comparison

Symbol% ChgMkt Cap
IRWDUp 0.23%1.82B
SHPGUp 0.66%36.32B
SCMPUp 0.76%350.15M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):57.90
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.35
Quarterly EPS Est (Sep-14) :-0.32
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-0.51

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ironwood Pharmaceuticals, Inc., an entrepreneurial pharmaceutical company, discovers, develops, and commercializes human therapeutic products. The company’s lead product candidate, linaclotide, a guanylate cyclase type-C agonist for irritable... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback